ML 348

Cat. No. 5345

ML 348 C18H17ClF3N3O3 [899713-86-1]

Price and Availability

For ML 348 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: N-[2-Chloro-5-(trifluoromethyl)phenyl]-4-(2-furanylcarbonyl)-1-piperazineacetamide

Biological Activity

Selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM). Exhibits 14-fold selectivity for LYPLA1 over LYPLA2. Also selective over a panel of ~30 other serine hydrolases.

Technical Data

M.Wt:
415.79
Formula:
C18H17ClF3N3O3
Solubility:
Soluble to 100 mM in DMSO
Purity:
>99 %
Storage:
Store at +4°C
CAS No:
899713-86-1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.

Certificate of Analysis / Product Datasheet / Safety Data Sheet

Adibekian et al (2013) Characterization of a Selective, Reversible Inhibitor of Lysophospholipase 2 (LYPLA2). Probe Reports from the NIH Molecular Libraries Program. PMID: 24624465.

If you know of a relevant reference for this product please let us know.

Citations are publications that use Tocris products.

Do you know of a great paper that uses ML 348 from Tocris? If so please let us know.

View Related Products by Target

View Related Products by Product Action

Keywords: ML 348, supplier, ML348, selective, reversible, lysophospholipase, 1, lypla1, inhibitors, inhibits, Tocris Bioscience, Other Hydrolase Inhibitor products

Quick Order

Find multiple products by catalog number

divider line

New Product Guide

New Product Guide (Fall/Winter 2016)

Our New Product guide highlights over 100 new products added in the second half of 2016. Request copy or view PDF today.

divider line

New Products in this Area

PDD 00017273

Potent and selective poly (ADP ribose) glycohydrolase (PARG) inhibitor; cell permeable

JZP 361

Potent and selective reversible MAGL inhibitor

URB 602

Non-competitive MAGL inhibitor

(S)-Crizotinib

MTH1 inhibitor

Sign-up for new product e-alerts
divider line

AACR 2017

Win a $1,000 travel grant

AACR travel Grant 2017

Bio-Techne is offering 10 travel grants of $1,000 for AACR 2017.